Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressant optiMization Using the Prospera Assay in Kidney Transplant (IMPAKT) Randomized Controlled Trial

NCT07718633 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT07718633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressant optiMization Using the Prospera Assay in Kidney Transplant (IMPAKT) Randomized Controlled Trial
Lead sponsor
Natera, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
July 31, 2031
Enrollment
750 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppresion, kidney transplant